格雷夫斯轨道病的肠道微生物群的调节:普雷沃特拉的主导地位和阿托瓦斯塔丁的影响
Danyu Wang1, Yaonan Chen1, Junpeng Yang1
1Department of Endocrinology, Henan Provincial Key Medicine Laboratory of Intestinal Microecology and Diabetes, Diabetes Microecology Diagnosis and Treatment and Transformation Engineering Research Center of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, China.
Microbiome
|December 30, 2025
概括
肠道微生物群的不平衡,特别是Prevotella,与Graves相关.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 肠道微生物群在Graves轨道病 (GO) 进展中的作用尚不清楚.
- 了解肠道微生物群在GO治疗中的功能至关重要.
研究的目的:
- 为了研究肠道微生物群在格雷夫斯轨道病变 (GO) 病原和治疗反应中的作用.
- 评估阿托瓦斯塔丁与静脉注射葡萄皮质类药物 (IVGC) 结合对GO的治疗效果.
主要方法:
- 便微生物群测序 (16S rRNA) 在GO,格雷夫斯病 (GD) 和健康对照 (HC) 患者中进行.
- 从GO患者到小鼠进行了便微生物群移植 (FMT).
- GO患者被随机分配,接受IVGC与阿托瓦斯塔丁或没有阿托瓦斯塔丁.
主要成果:
- GO患者表现出明显的肠道微生物群,增加了Prevotella和Bacteroides.
- 来自GO患者的FMT在小鼠中诱导了类似疾病的症状.
- 阿托瓦斯塔丁与IVGC结合,改善了眼部症状和调节了肠道微生物群.
结论:
- 肠道微生物群失调,特别是Prevotella,有助于GO的发展.
- 阿托瓦斯塔丁可以通过恢复肠道微生物群平衡来缓解GO的进展.
相关概念视频
Gastritis-II: Pathophysiology
1.1K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
Peptic Ulcer Disease II: Pathophysiology
1.8K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.8K
Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Gastrointestinal Motility Disorders
1.0K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.0K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
400
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
400


